• Health Effects of Ultra-processed Food Intake

  NCT07634159

  RecruitingInterventionalNot ApplicableUpdated Aug 24, 2026
• Impact of Ultra-processed Foods on Cardiometabolic Risk Factors

  NCT06538831

  RecruitingInterventionalNot ApplicableUpdated Oct 17, 2024
• Metabolomics-Driven Insights Into Ultra-Processed Foods

  NCT07717970

  Not yet recruitingInterventionalNot ApplicableUpdated Jul 21, 2026
• Highly Processed Foods and Vascular Health

  NCT05628350

  CompletedInterventionalNot ApplicableUpdated Jan 22, 2026
• Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF)

  NCT07213245

  RecruitingInterventionalNot ApplicableUpdated Dec 15, 2025
• Diet-induced Arrangement of the Gut Microbiome for Improvement of Cardiometabolic Health

  NCT03071718

  CompletedInterventionalNot ApplicableUpdated Jul 19, 2019

ClinicalTrials.gov ID

NCT06314932

Lead Sponsor

University of MilanOTHER

Overall Status

Unknown status

Study Type

Interventional

Phase

Not Applicable

Enrollment

50Estimated

Last Update Posted

Mar 18, 2024Actual

Start Date

Apr 2024Estimated

Primary Completion Date

Oct 2024Estimated

Completion Date

Jun 2025Estimated

Official Title

Role of ultraPROcessed Foods in Modulating the Effect of mEditerraNeAn Diet on Human and Planet hEalth - the PROMENADE Study

Brief Summary

Mediterranean diet is worldwide promoted as one of the healthiest and most sustainable dietary patterns. One of the main pillars of Mediterranean diet is the abundant consumption of plant-based ingredients typically consumed as raw or minimally processed. However, even in the Mediterranean countries, these fresh foods are increasingly replaced by ultra-processed foods (UPF). Epidemiological evidence suggests that consumption of UPF may be detrimental to human health, but there is only one clinical trial on this topic which is largely debated in the scientific community due to limitations related to the short duration of the trial and the composition of dietary interventions.

The present study aims at exploring whether the inclusion of UPF within a Mediterranean-based dietary pattern can impact on cardiometabolic markers, gut microbiota and other health markers in a dietary intervention performed in Italian subjects. For this purpose, 50 clinically healthy subjects will be recruited for a 7-month randomized, open, cross-over dietary trial. Eligible participants will be randomly assigned to consume a 3-month Mediterranean diet high in UPF (intervention group) or a low-UPF Mediterranean diet (control group), spaced by a 1-month wash-out period. The two diets will have the same composition in terms of food groups. However, in the high-UPF Mediterranean diet group, 5 servings/day of UPF, as defined by the NOVA system, will be consumed (e.g., flavored yogurt, breakfast cereals with added sugar, processed meat). In the control group, these foods will be replaced by products from the same food group, but not UPF (e.g., plain yogurt, breakfast cereals with no added sugar, unprocessed meat). The inflammatory potential of pairs of food products, both UPF and non UPF, will be evaluated using an in vitro cell model testing the modulation of inflammatory markers. Before and after each intervention blood, urine and fecal samples will be collected. The primary endpoint is change in low-density lipoprotein (LDL) cholesterol levels from baseline. Among the other markers, blood pressure and anthropometric parameters will be measured; biochemical parameters, adipokines, inflammatory and oxidative stress markers, fecal microbiota composition and short chain fatty acids (SCFAs) will be analyzed. Adherence to the study, dietary intake and food waste production will be evaluated through specific food diaries, useful also for estimating the metabolic food waste.

• Overweight

• MD high in UPF
• MD low in UPF

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• age >18 years
• BMI between 25.0 and 29.9 kg/m2 and the simultaneous presence of at least one of the following criteria, defined by the Guidelines for cardiovascular disease prevention of the European Society of Cardiology:
• total cholesterol levels >190 mg/dL
• LDL-cholesterol levels >115 mg/dL
• triglyceride levels >150 mg/dL
• glucose levels in the range 111-125 mg/dL

Exclusion Criteria:

• presence of current serious illness or unstable condition that requires physician supervision of diet (e.g., recent myocardial infarction, chronic liver disease, inflammatory bowel diseases, renal or digestive disorders)
• pregnancy or intention to become pregnant in the next 12 months
• lactation
• current or recent (past 3 months) use of supplements or antibiotic therapy
• current or recent (past 6 months) adoption of specific restrictive diets (e.g., low-calorie or vegetarian diets)

Primary Purpose

Prevention

Allocation

Randomized

Interventional Model

Crossover Assignment

Masking

Single

Lead Sponsor

University of MilanOTHER

Collaborators

University of FlorenceOTHER

University of TeramoOTHER

daniela.martini@unimi.it+39 02503 16727